- Home
- PBYI vs ONT Comparison
PBYI vs ONT Comparison
Compare PBYI & ONT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | ONT |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.1M | 503.6M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PBYI | ONT |
|---|---|---|
| Price | $10.44 | $14.94 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $18.20 |
| AVG Volume (30 Days) | 339.7K | ★ 619.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.69 |
| EPS | ★ 0.08 | N/A |
| Revenue | $27,685,000.00 | ★ $830,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.33 | $8.17 |
| P/E Ratio | $132.06 | ★ N/A |
| Revenue Growth | N/A | ★ 19.26 |
| 52 Week Low | $4.58 | $12.35 |
| 52 Week High | $11.50 | $23.32 |
Technical Indicators
Market Signals| Indicator | PBYI | ONT |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 52.09 |
| Support Level | $9.04 | $14.39 |
| Resistance Level | $11.50 | $18.32 |
| Average True Range (ATR) | 0.46 | 0.76 |
| MACD | -0.04 | 0.23 |
| Stochastic Oscillator | 39.77 | 85.68 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ONT Onterris Inc. Common Stock
Onterris Inc is an environmental solutions company. The company provides environmental solutions to organizations addressing regulatory, operational, and environmental challenges. Its services include the application of scientific, engineering, and data-driven approaches to support risk management, compliance, and environmental protection, including air, water, and soil.